English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Gilead Sciences Inc. Healthcare Policy PAC
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Trending
+
Pharmaceuticals
Patient Daily
| Jun 2, 2025
PathAI collaborates with Northwestern Medicine on digital pathology advancements
+
Pharmaceuticals
Patient Daily
| May 29, 2025
Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+
Regulatory
Patient Daily
| May 30, 2025
Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation
+
Pharmaceuticals
Patient Daily
| May 28, 2025
University of California medical researcher: ‘The 340B program is not associated with an improvement in mortality for low-income patients'
